Alkem Laboratories Ltd.

NSE: ALKEM | BSE: 539523 | ISIN: INE540L01014 | Industry: Pharmaceuticals
| Strong Performer, Getting Expensive
5674.5000 27.00 (0.48%)
NSE Dec 04, 2025 10:44 AM
Volume: 10,254
 

logo
Alkem Laboratories Ltd.
03 Nov 2018, 03:19PM
5674.50
0.48%
buy
by HDFC Securities
HDFC Securities
Alkem Laboratories Ltd Q2FY19 results Comment Revenue rose by 14.94% to Rs. 1918.92 Cr in Q2FY19 when compared to the previous quarter. Also, it rose by 3.22% when compared with Q2FY18.
 
ICICI Securities Limited increased Buy price target of Alkem Laboratories Ltd. to 6600.0 on 14 Nov, 2025.
More from Alkem Laboratories Ltd.
Recommended
Market trades higher, Petronet LNG signs Rs 5,000 crore agreement with ONGC
Trendlyne Marketwatch | 04 Dec 2025, 10:23AM
Could Rs 90 per dollar be good for India?
The Baseline | 03 Dec 2025, 12:23PM
Alkem Laboratories hopes to fire up its US business to fuel future growth
| 02 Jul 2021